Here's my read on who might like B-D: 1) Tyco...Medical division. Could add to earnings immediately, which is a stated goal. They could slash $250-400M of costs out and get extra leverage w/ purchasing in the hospital market. Score 9.0 (out of 10). 2) J&J. Would like to add B-D's clout in diabetes with their $1B Lifescan division. The diagnostics would be a fit also. Syringes is a push. Cost savings could even be greater given location. Score 8.5 3)Roche / BMD. Ditto to J&J accross the board. Score 8.5 4)Abbott. Ditto again, although Abbott has a syringe deal with Sherwood, and could value diagnostics lower Score 7.5-8.0 5) Cardinal Health (DARK HORSE). Good fit with their long term care, disease mgt, pharmacy, and Allegiance hospital and laboratory supply divisions. They have been putting out big bucks recently. Score 7.0 but could go up.
Net net...B-D could be in play and at these prices it's a very tempting morsel.